Generalized myasthenia gravis
Conditions
Interventions
Observation group:NA
Sponsors
Huashan Hospital, Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged > = 18 years and < = 70 years; 2. Patients diagnosed with generalized myasthenia gravis, positive or negative antibodies to anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK); 3. MGFA clinical classification type II-IVa; 4. Patient has one or more of the following treatment experiences: (1) plasmapheresis; (2) Acetylcholinesterase (AChE) inhibitors: pyridostigmine bromide, etc.; (3) glucocorticoids; (4) Non-steroidal immunosuppressants: azathioprine, tacrolimus, MMF, cyclosporine, methotrexate, cyclophosphamide, etc.; (5) Targeted biological agents: rituximab, agamod, etc.
Exclusion criteria
Exclusion criteria: 1.Currently participating in any other intervention clinical studies related to MG; 2. Not capable of completing questionnaire surveys.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient preferences; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction;Willingness to pay; | — |
Countries
China
Contacts
Public ContactChongbo Zhao
Huashan Hospital, Fudan University
Outcome results
None listed